Abstract
A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
Original language | English |
---|---|
Pages (from-to) | 935-938 |
Number of pages | 4 |
Journal | Trends in Neurosciences |
Volume | 43 |
Issue number | 12 |
DOIs | |
Publication status | Published - 22 Oct 2020 |
Keywords
- PET radiotracers
- SARS-CoV-2
- neurological manifestations